Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/01/2006 | CN1853678A Chinese medicinal preparation for treating heart cerebrovascular disease and making method thereof |
11/01/2006 | CN1853677A Chinese medicine for heart disease |
11/01/2006 | CN1853676A Chinese Magnoliavine Fruit alcohol extract drip balls and preparation thereof |
11/01/2006 | CN1853675A Compound Silybum drip balls and preparation thereof |
11/01/2006 | CN1853672A Composition containing butylbenzene peptide |
11/01/2006 | CN1853671A Thrombolytic collaterals-activating preparation for treating angiitis and phlebitis and making method thereof |
11/01/2006 | CN1853670A Coronary heart Danshen root micropellets and preparation thereof |
11/01/2006 | CN1853669A Swertia milleensis general glycoside drip balls and preparation thereof |
11/01/2006 | CN1853668A Chinese medicinal composition for strengthening body and enriching blood |
11/01/2006 | CN1853665A Effective antiviral part of isatis root |
11/01/2006 | CN1853664A Medicinal composition for treating wound and preparation thereof |
11/01/2006 | CN1853662A Pearl cosmetic tablets |
11/01/2006 | CN1853660A Erigeron breviscapus preparation and making method thereof |
11/01/2006 | CN1853659A Xinnao Shutong soft capsule and preparation thereof |
11/01/2006 | CN1853656A Fermentation composition having immunomodulating effect |
11/01/2006 | CN1853655A Oral colon target preparation for treating colitis ulcerativa and its making method |
11/01/2006 | CN1853654A Oral preparation containing pearl and vitamine |
11/01/2006 | CN1853652A Chinese medicinal gel preparation for treating ophthalmologic disease |
11/01/2006 | CN1853651A Medicinal composition containing cinnabar or/and realgar |
11/01/2006 | CN1853650A Calcium-supplementing agent |
11/01/2006 | CN1853648A Intraoral glue composition for releasing dental exulceratio pain |
11/01/2006 | CN1853643A Composition of self-microemulsion puerarin oral preparation and use thereof |
11/01/2006 | CN1853641A Glycyrrhiza edulcorant drip ball and production thereof |
11/01/2006 | CN1853640A Doxycycline hyclate liposome and production thereof |
11/01/2006 | CN1853636A Citric acid Mosabily oral liquid |
11/01/2006 | CN1853635A Use of triazinetrione sulfones for combating coccidiosis |
11/01/2006 | CN1853634A Composition comprising itraconazole for oral administration |
11/01/2006 | CN1853632A Herba fibraurae recisae soft capsules and production thereof |
11/01/2006 | CN1853631A Fast disintegrant containing paroxetine |
11/01/2006 | CN1853629A Berberine dripping balls and preparation thereof |
11/01/2006 | CN1853628A Preparing method for injection containing benzimidazole derivative |
11/01/2006 | CN1853627A Cyclodextrin of bibenziisosehenazole ethane or cyclodextrin derivative inclusion compound, and preparation and use thereof |
11/01/2006 | CN1853626A Zinc sulfate freeze-dried preparation for injection |
11/01/2006 | CN1853625A Combination of sweet-scented osmanthus and plantinum chemotherapeutic medicine |
11/01/2006 | CN1853624A Fat emulsion containing tanshinone analog and use thereof |
11/01/2006 | CN1853623A Use of hellebore alkaloid in tumor treatment |
11/01/2006 | CN1853621A Use of pinolenic acid |
11/01/2006 | CN1853620A Fat emulsion of houttuynin analog |
11/01/2006 | CN1853618A Use of bromphenol compound in protein-tyrosine phosphonatease inhibitor |
11/01/2006 | CN1853617A Medicine based on anti-hyperglycaemic microcapsules with prolonged release |
11/01/2006 | CN1853616A Preparation of floridean polysaccharide vegetable prandial fiber medicinal hard capsule |
11/01/2006 | CN1853615A Tablet containing brufen and producing process thereof |
11/01/2006 | CN1853614A Decoloring method and decoloring agent for quinolone injection |
11/01/2006 | CN1853609A Skin-care effectiveness applied by acid fiber mother cell growth factor (FGF-1) |
11/01/2006 | CN1853492A Pearl-milk chewing tablets |
11/01/2006 | CN1282748C Method for preparing leukocyte interferon of pig |
11/01/2006 | CN1282656C HIV peptides from conserved regions in GAGP 17 and 924 and their application in e.g. vaccines |
11/01/2006 | CN1282483C Slow-releasing oxytocic for artificial inducting maturation and ovulation and ejaculation rockfish and use |
11/01/2006 | CN1282480C Head ache capsule preparation |
11/01/2006 | CN1282479C Slowly-released traditional Chinese medicine adhering tablet for treating mouth mucous diseases and its prepn. method |
11/01/2006 | CN1282475C Combination of medication for treating gallbladder disease and preparation method |
11/01/2006 | CN1282472C Anthemonhagic medicament for quick blood coagulation and diminish inflammation |
11/01/2006 | CN1282471C Medicine for treating anaphylactic dermatosis |
11/01/2006 | CN1282470C Traditional Chinese medicine for anti depression |
11/01/2006 | CN1282468C Chinese medicine soft capsule Naodesheng and its preparing method |
11/01/2006 | CN1282467C Medicine for treating coronary disease and stenocardia and its preparation method |
11/01/2006 | CN1282465C Injection liquid in use for intravenous injection and preparation method |
11/01/2006 | CN1282464C Chinese medicinal preparation and preparing method for chronic heart fatilue |
11/01/2006 | CN1282461C Trichosanthes peel injection and its preparation method |
11/01/2006 | CN1282460C Chinese traditional medieine for treating cold and preparing technique |
11/01/2006 | CN1282459C Progesterone capsule and preparing method thereof |
11/01/2006 | CN1282458C Cefadroxil dry suspension and preparing method |
11/01/2006 | CN1282456C Paroxetine control-released composite |
11/01/2006 | CN1282425C Apple vinegar nutritious product and its producing method |
10/31/2006 | US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
10/31/2006 | US7129293 poly(ethylene glycol)-block-poly(dialkylaminoethyl methacrylate) form polymer micelle via an anionically charged polymer; carriers for organic drug represented by oligo- or polynucleotide, and ultrafine particles of inorganic substances represented by semiconductor, free electron metal or metal oxide |
10/31/2006 | US7129277 Emulsions including surface-modified inorganic nanoparticles |
10/31/2006 | US7129275 Compositions for treating acne comprising phytandiol amine |
10/31/2006 | US7129222 Immunomodulatory formulations and methods for use thereof |
10/31/2006 | US7129219 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group |
10/31/2006 | US7129218 Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration |
10/31/2006 | US7129210 cross-linkable protein in the form of a solution or suspension; cross-linking agent solution includes an aldehyde and an amino acid containing species reactive with the aldehyde |
10/31/2006 | US7129208 Synthetic ion channels |
10/31/2006 | US7129087 Anchoring oligonucleotides; incubation |
10/31/2006 | US7128933 Reducing odors; using mixture containing plant extracts |
10/31/2006 | US7128931 Semi-permeable microcapsule with covalently linked layers and method for producing same |
10/31/2006 | US7128930 Topically administering to the genitals of a patient with sexual dysfunction an ethyl ester of L-arginine, combination of ascorbic acid and ascorbic acid palmitate as antioxidants to cause the desired level of blood flow to erectile tissue while minimizing peroxynitrite levels |
10/31/2006 | US7128928 Ophthalmic formulation with novel gum composition |
10/31/2006 | US7128927 Emulsions for in-situ delivery systems |
10/31/2006 | US7128925 Device for applying active principles for pharmaceutical or cosmetic purposes |
10/31/2006 | US7128922 Compositions of leukaemia inhibitory factor |
10/31/2006 | US7128911 Virus-like particle, and an antigen or antigenic determinant of a receptor activator factor kappa beta ligand protein, fragment or peptide |
10/31/2006 | US7128909 For parenteral or mucosal administration of antigens and/or vaccines to humans and animals |
10/31/2006 | US7128900 Light-protection agents |
10/31/2006 | US7128897 Having surface tension, effective for therapy of respiratory systme disorders |
10/31/2006 | US7128067 Method and apparatus for generating an aerosol |
10/31/2006 | CA2333405C Spill resistant pharmaceutical compositions |
10/31/2006 | CA2329217C Stable extended release oral dosage composition comprising desloratadine and pseudoephedrine |
10/31/2006 | CA2321780C Method and device for inserting a plurality of individual sheetlike forms of administration in a dispenser by forming a multilayer pile |
10/31/2006 | CA2302850C Stretch mask with an adhesive matrix that can be extended at least when wet |
10/31/2006 | CA2285180C Intravaginal drug delivery system and discharge collection device |
10/31/2006 | CA2281474C Dosage forms exhibiting multiphasic release kinetics and methods of manufacture thereof |
10/31/2006 | CA2267160C Antimycotic gel for the treatment and prevention of skin mycoses |
10/31/2006 | CA2250025C Transdermal therapeutic system with small application-area thickness and great flexibility, and production process |
10/31/2006 | CA2236925C Microencapsulated dna for vaccination and gene therapy |
10/31/2006 | CA2209303C Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists |
10/31/2006 | CA2190370C Composition and method for enhancing transdermal electrotransport agent delivery |
10/31/2006 | CA2188599C Taxane class derivative based pharmaceutical compositions |
10/31/2006 | CA2157376C Vaccine compositions containing 3-o deacylated monophosphoryl lipid a |
10/31/2006 | CA2142811C Novel glucan preparation |